TabacaleraYsidron is Other Consumer Non-Durables in United States that focus on TAM Biotechnologies Inc business. Founded in 2011. They cover business area such as Mount TAM Biotechnologies Inc, its core business, a portfolio, product, wellbeing, individual, serious disease, systemic lupus erythematosus, SLE, market, novel therapeutic, an autoimmune disorder, treatment, a condition, serious unmet, novel rapalog, action, binding, inhibition, Rapamycin.
2011
( 13 years old in 2024 )
TAM Biotechnologies Inc
-
100 Europa Drive
Suite 455
Chapel Hill, NC 27517
United States
Private
Mount TAM Biotechnologies Incits core businessa portfolioproductwellbeingindividualserious diseasesystemic lupus erythematosusSLEmarketnovel therapeutican autoimmune disordertreatmenta conditionserious unmetnovel rapalogactionbindinginhibitionRapamycin
* We use standard office opening hours in near TabacaleraYsidron's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
TabacaleraYsidron is Other Consumer Non-Durables business from United States that founded in 2011 (13 years old in 2024), TabacaleraYsidron business is focusing on TAM Biotechnologies Inc.
TabacaleraYsidron headquarter office and corporate office address is located in 100 Europa Drive Suite 455 Chapel Hill, NC 27517 United States.
TabacaleraYsidron was founded in United States.
In 2024, TabacaleraYsidron is currently focus on TAM Biotechnologies Inc sector.
Above is snippet of Google Trends for "TAM Biotechnologies Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with TabacaleraYsidron, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
